Skip to main content

Articles

Page 4 of 17

  2. Venous thromboembolism (VTE) including Deep Venous Thrombosis (DVT) and Pulmonary Embolism (PE), is a serious cause of patient morbidity and mortality in hospitals. Neurosurgical hospitalized patients have hig...

    Authors: Pan Lin, James Allen Wiley, Lingyun Tian, Wan Li, Qiuhong Yang, Haifan Yang, Xin Tan, Yijing Gao, Weijuan Li, Hui Luo, Xinyu Feng and Yinglan Li
    Citation: Thrombosis Journal 2023 21:30
    Content type: Research Published on:

  3. Cronkhite-Canada syndrome (CCS) is a rare disease characterized by generalized gastrointestinal polyps, ectodermal abnormalities and variable gastrointestinal symptoms. Few cases to date have described complic...

    Authors: Xiao-Kai Feng, Xiao-Fen Chen, Bei-Bei Wang, Zhi-Gang Zeng, Chao Liu, Wei-Hong Sha and Juan Ma
    Citation: Thrombosis Journal 2023 21:29
    Content type: Case Report Published on:

  4. Risk prediction rules are important to establish appropriate treatment and management strategy for patients with different risk classification of pulmonary embolism (PE). Neutrophils are considered to be relat...

    Authors: Rui Peng, Weihua Yin, Fang Wang, Xiangfeng Cong, Bin Lu, Lu Hua and Xi Chen
    Citation: Thrombosis Journal 2023 21:28
    Content type: Research Published on:

  5. Thrombolysis-related intracranial hemorrhage has a high mortality rate, and many factors can cause intracranial hemorrhage. Until now, systematic reviews and assessments of the certainty of the evidence have n...

    Authors: Jiana Chen, Zhiwei Zeng, Zongwei Fang, Fuxin Ma, Meina Lv and Jinhua Zhang
    Citation: Thrombosis Journal 2023 21:27
    Content type: Research Published on:

  6. Transplantation-associated thrombotic microangiopathy (TA-TMA) is an endothelial injury syndrome linked to the overactivation of complement pathways. It manifests with microangiopathic hemolytic anemia, consum...

    Authors: Ambreen Pandrowala, Parth Ganatra, V. P. Krishnan, Ajay Narayan Sharma, Saroj Chavan, Minnie Bodhanwala, Bharat Agarwal and Prashant Hiwarkar
    Citation: Thrombosis Journal 2023 21:26
    Content type: Case Report Published on:

  7. The present study aimed to investigate the preliminary safety and efficacy of rheolytic thrombectomy (RT) using an AngioJet Zelante DVT catheter or a Solent Omni catheter for acute proximal deep vein thrombosi...

    Authors: Maofeng Gong, Guanqi Fu, Zhengli Liu, Yangyi Zhou, Jie Kong, Boxiang Zhao, Wensheng Lou, Jianping Gu and Xu He
    Citation: Thrombosis Journal 2023 21:25
    Content type: Research Published on:

  8. It has been shown that long non-coding RNA (lncRNA) LINC00659 was markedly upregulated in the peripheral blood of patients with deep venous thrombosis (DVT). However, the function of LINC00659 in lower extremi...

    Authors: Bo Zhang and Jie Qin
    Citation: Thrombosis Journal 2023 21:24
    Content type: Research Published on:

  9. The use of viscoelastic tests is becoming increasingly popular. There is a paucity of validation of the reproducibility of varying coagulation states. Therefore, we aimed to study the coefficient of variation ...

    Authors: Lotta Sunnersjö, Henrik Lindström, Ulf Schött, Noa Törnquist and Thomas Kander
    Citation: Thrombosis Journal 2023 21:23
    Content type: Research Published on:

  10. To investigate venous thromboembolism (VTE) in hospitalized patients with severe high altitude pulmonary edema (HAPE), we performed a single center retrospective study to evaluate its clinical characteristics,...

    Authors: Yanmin Liu, Xinwei Feng, Yongxue Tang, Yanqiu Sun, Xiaoyan Pu and Xiaokai Feng
    Citation: Thrombosis Journal 2023 21:22
    Content type: Research Published on:

  11. Anti-factor Xa assays and activated partial thromboplastin time (aPTT) are mainly employed to monitor patients treated with heparins. According to the Clinical and Laboratory Standards Institute and the French...

    Authors: Marion Gremillet, Laurie Talon, Aurélien Lebreton and Thomas Sinegre
    Citation: Thrombosis Journal 2023 21:21
    Content type: Research Published on:

  12. Hypocalcemia has been shown to be involved in the adverse outcomes of acute pulmonary embolism (APE). We aimed to determine the incremental value of adding hypocalcemia, defined as serum calcium level ≤ 2.12 m...

    Authors: Jiarui Zhang, Adila Ali, Yu Liu, Lige Peng, Jiaqi Pu, Qun Yi and Haixia Zhou
    Citation: Thrombosis Journal 2023 21:20
    Content type: Research Published on:

  14. Integrins are heterodimeric receptors comprising α and β subunits. They are expressed on the cell surface and play key roles in cell adhesion, migration, and growth. Several types of integrins are expressed on...

    Authors: Honglei Xin, Jiansong Huang, Zhiqun Song, Jianhua Mao, Xiaodong Xi and Xiaofeng Shi
    Citation: Thrombosis Journal 2023 21:18
    Content type: Review Published on:

  15. Studies on the incidence of venous thromboembolism (VTE) events in patients with interstitial lung disease (ILD) are limited and the results are inconsistent. The aim of this research was to investigate the in...

    Authors: Haishuang Sun, Min Liu, Xiaoyan Yang, Linfeng Xi, Wenqing Xu, Mei Deng, Yanhong Ren, Wanmu Xie, Huaping Dai and Chen Wang
    Citation: Thrombosis Journal 2023 21:17
    Content type: Research Published on:

  16. Data that guide selection of differing anticoagulant regimens for specific cancer-associated venous thromboembolism (VTE) are lacking. We aimed to compare the efficacy and safety of rivaroxaban and low-molecul...

    Authors: Yijun Song, Dawei Yang, Dongni Hou, Jun She and Yuanlin Song
    Citation: Thrombosis Journal 2023 21:16
    Content type: Research Published on:

  17. The optimal duration and choice of anticoagulant for the treatment of Peripherally inserted central catheters (PICC)-related upper extremity deep vein thrombosis (UEDVT) in cancer patients are still undetermined.

    Authors: Jiaxuan Xu, Guodong Wang, Xiaojie Chen, Yanfen Shen, Xinpeng Wang and Hongzhi Wang
    Citation: Thrombosis Journal 2023 21:15
    Content type: Research Published on:

  18. Coronavirus disease 2019 (COVID-19) is associated with provoked thrombo-inflammatory responses. Early in the COVID-19 pandemic this was thought to contribute to hypercoagulability and multi-organ system compli...

    Authors: Mohamed S. Zaghloul, Momodou Jammeh, Andrew Gibson, Suhong Luo, Kelley Chadwick-Mansker, Qianjin Liu, Yan Yan and Mohamed A. Zayed
    Citation: Thrombosis Journal 2023 21:14
    Content type: Research Published on:

  19. The role of anticoagulants in the treatment of cirrhotic PVT remains controversial. This study aimed to analyze the safety and efficacy of anticoagulant therapy in patients with cirrhotic portal vein thrombosi...

    Authors: Zhiqi Zhang, Ying Zhao, Dandan Li, Mingxing Guo, Hongyu Li, Ranjia Liu and Xiangli Cui
    Citation: Thrombosis Journal 2023 21:13
    Content type: Research Published on:

  20. The hyper-coagulopathy nature of COVID-19 is a prevalent consequence among patients. Free-floating right atrial thrombi are a relatively rare finding and the optimal therapy is a therapeutic dilemma.

    Authors: Mahsa Mahjani, Sepehr Gohari and Hassan Ahangar
    Citation: Thrombosis Journal 2023 21:12
    Content type: Case Report Published on:

  21. Extracorporeal membrane oxygenation (ECMO) can provide life-saving support for critically ill patients suffering severe respiratory and/or cardiac failure. However, thrombosis and bleeding remain common and co...

    Authors: Saeedreza Zeibi Shirejini, Josie Carberry, Zoe K. McQuilten, Aidan J. C. Burrell, Shaun D. Gregory and Christoph E. Hagemeyer
    Citation: Thrombosis Journal 2023 21:11
    Content type: Review Published on:

  22. Tranexamic acid (TXA) is an antifibrinolytic drug that blocks lysine-binding sites on the profibrinolytic enzyme plasminogen. Aortic diseases with chronic consumption coagulopathy may lead to disseminated intr...

    Authors: Naruko Suzuki, Nobuaki Suzuki, Yuka Kawaguchi, Shuichi Okamoto, Takeshi Kanematsu, Akira Katsumi, Atsuo Suzuki, Shogo Tamura, Tetsuhito Kojima, Hitoshi Kiyoi and Tadashi Matsushita
    Citation: Thrombosis Journal 2023 21:10
    Content type: Research Published on:

  23. Portal vein thrombosis is a common complication of liver cirrhosis and hepatocellular carcinoma; however, few studies have reported its long-term clinical prognosis. This study aimed to establish and validate ...

    Authors: Xuan Zhong, Shan Li, Jiali Hu, Jinlai Lu, Wei Wang, Miao Hu, Qinjuan Sun, Shuo Zhang, Xiaoqing Yang, Changqing Yang and Lan Zhong
    Citation: Thrombosis Journal 2023 21:9
    Content type: Research Published on:

  24. The assessment of VTE likelihood with VTE risk scores is essential prior to imaging examinations during VTE diagnostic procedure. Little is known with respect to the disparity of predictive power for VTE diagn...

    Authors: Wei Xiong, Yunfeng Zhao, Yi Cheng, He Du, Jinyuan Sun, Yanmin Wang, Mei Xu and Xuejun Guo
    Citation: Thrombosis Journal 2023 21:8
    Content type: Research Published on:

  25. Several prior studies postulated an effect of hypertension on coagulation factors. However, population-based studies investigating the sex-specific associations between hypertension and hemostatic parameters a...

    Authors: J. Vogel von Falckenstein, D. Freuer, A. Peters, M. Heier, J. Linseisen and C. Meisinger
    Citation: Thrombosis Journal 2023 21:7
    Content type: Research Published on:

  26. Cavernous transformation of the portal vein (CTPV) in cirrhotic patients with extrahepatic portal vein obstruction (EHPVO) was a relatively rare disease and had no consensus on the treatment. Our study aimed t...

    Authors: Yongjie Zhou, Zhiquan Zhuang, Tianzhu Yu, Wen Zhang, Jingqin Ma, Jiaze Yu, Zhiping Yan and Jianjun Luo
    Citation: Thrombosis Journal 2023 21:6
    Content type: Research Published on:

  27. Patients with peripheral artery disease (PAD) are treated with preventive strategies to improve the cardiovascular risk. The incidence of cardiovascular events and mortality however remains high in PAD populat...

    Authors: B. M. M. Kremers, J. H. C. Daemen, H. ten Cate, H. M. H. Spronk, B. M. E. Mees and A. J. ten Cate-Hoek
    Citation: Thrombosis Journal 2023 21:5
    Content type: Research Published on:

  28. Extracorporeal membrane oxygenation (ECMO) is applied in patients with respiratory or cardiopulmonary failure, but bleeding is a frequent complication contributing to the high mortality rates in this patient c...

    Authors: Martin Büchsel, Ulrich Geisen, Clara Beckenkamp, Tobias Wengenmayer, Barbara Zieger, Dirk Westermann and Patrick M. Siegel
    Citation: Thrombosis Journal 2023 21:4
    Content type: Research Published on:

  29. Antithrombin (AT) is the main physiological anticoagulant involved in hemostasis. Hereditary AT deficiency is a rare autosomal dominant thrombotic disease mainly caused by mutations in SERPINC1, which was usually...

    Authors: Han-lu Wang, Dan-dan Ruan, Min Wu, Yuan-yuan Ji, Xing-xing Hu, Qiu-yan Wu, Yan-ping Zhang, Bin Lin, Ya-nan Hu, Hang Wang, Yi Tang, Zhu-ting Fang, Jie-wei Luo, Li-sheng Liao and Mei-zhu Gao
    Citation: Thrombosis Journal 2023 21:3
    Content type: Research Published on:

  30. Fusobacterium nucleatum (F. nucleatum) often colonizes cancerous gastric tissues and is characterized by the promotion of platelet aggregation and the development of visceral thrombosis. Venous thromboembolism (V...

    Authors: Chang Liu, Zhou Yang, Xiance Tang, Fangfang Zhao, Mengke He, Changpeng Liu, Dongmin Zhou, Lifeng Wang, Bo Gu, Yiqiang Yuan and Xiaobing Chen
    Citation: Thrombosis Journal 2023 21:2
    Content type: Research Published on:

  31. (p-BthTX-I)2 K, a dimeric analog peptide derived from the C-terminal region of phospholipase A2-like bothropstoxin-I (p-BthTX-I), is resistant to plasma proteolysis and inhibits severe acute respiratory syndrome ...

    Authors: Ruben Siedlarczyk Nogueira, Bruno Ramos Salu, Vinícius Goulart Nardelli, Camila Ramalho Bonturi, Marina Rodrigues Pereira, Francisco Humberto de Abreu Maffei, Eduardo Maffud Cilli and Maria Luiza Vilela Oliva
    Citation: Thrombosis Journal 2023 21:1
    Content type: Research Published on:

  32. The prognostic implication of liver fibrosis in acute coronary syndrome (ACS) patients are scarce. We sought to evaluate whether liver fibrosis scores (LFS) were associated with thrombotic or bleeding events i...

    Authors: Yupeng Liu, Jingjing Song, Wenyao Wang, Kuo Zhang, Jie Yang, Jun Wen, Xiangbin Meng, Jun Gao, Jingjia Wang, Chunli Shao and Yi-Da Tang
    Citation: Thrombosis Journal 2022 20:82
    Content type: Research Published on:

  33. Mutations in SERPINC1 lead to deficiency in antithrombin (AT) which is an endogenous anticoagulant of normal hemostasis and could result in venous thromboembolism (VTE).

    Authors: Teng Huang, Yu Liu, Xiaofeng Jiang, Wei Zhang, Honglian Zhou and Qi Hu
    Citation: Thrombosis Journal 2022 20:81
    Content type: Case Report Published on:

  34. Postoperative pulmonary embolism (PE) is a severe complication leading to death and poor prognosis. The present study investigated the risk factors and potential predictors of PE in cancer patients undergoing ...

    Authors: Yi Li, Zhenjun Liu, Chen Chen, Dan Li, Huan Peng, Pei Zhao and Jiuhui Wang
    Citation: Thrombosis Journal 2022 20:80
    Content type: Research Published on:

  35. Tranexamic acid (TXA) plays a significant role in the treatment of traumatic diseases. However, its effectiveness in patients with traumatic brain injury (TBI) seems to be contradictory, according to the recen...

    Authors: Honghao Huang, Mei Xin, Xiqiang Wu, Jian Liu, Wenxin Zhang, Ke Yang and Jinbao Zhang
    Citation: Thrombosis Journal 2022 20:79
    Content type: Research Published on:

  36. To assess the immediate effect and factors affecting the efficacy of rotational thrombectomy (RT) in patients with thrombus-containing lower-limb ischaemic lesions.

    Authors: Jinyan Xu, Qingyuan Yu, Guanglang Zhu, Zhiqing Zhao, Yu Xiao, Junmin Bao and Liangxi Yuan
    Citation: Thrombosis Journal 2022 20:78
    Content type: Research Published on:

  37. Thromboembolism was a chief cause of mortality in 70% of patients with COVID-19. Our objective was to see if serum interleukins 1 beta (IL-1β) and soluble platelets selectin (sP-selectin) could serve as novel ...

    Authors: Sara El-Sayed Abd El-Ghani, Reham Mohammad Raafat Hamed, Ragaey Ahmad Eid, Ahmed Yassin Mohammed Ibrahim, Hoda M. Abdel-Hamid, Walaa Abdelrahman, Raghda Ebaid Ibrahim, Manar Mahmoud Abdel-Aziz and Marwa Salah Mohamed
    Citation: Thrombosis Journal 2022 20:77
    Content type: Research Published on:

  38. Thromboelastometry is considered the best method to assesses hemostasis in liver disease. Diagnostic performance could be improved by adding protein C activators such as thrombomodulin or Protac®.

    Authors: Andrea Calvo, Miguel Angel Torrente, Klaus Görlinger, Javier Fernandez, Enric Reverter, Julia Vidal, Dolors Tassies, Jordi Colmenero, Annabel Blasi and Juan Carlos Reverter
    Citation: Thrombosis Journal 2022 20:75
    Content type: Research Published on:

  39. Critically ill patients in intensive care units (ICUs) are at high risk of venous thromboembolism (VTE). This study aimed to explore the prophylaxis effect under a guideline-based thromboprophylaxis protocol a...

    Authors: Xiao Tang, Wen-Rui Lyu, Yu Jin, Rui Wang, Xu-Yan Li, Ying Li, Chun-Yan Zhang, Wei Zhao, Zhao-Hui Tong and Bing Sun
    Citation: Thrombosis Journal 2022 20:76
    Content type: Research Published on:

  40. Thrombotic events are common in critically ill patients with COVID-19 and have been linked with COVID-19- induced hyperinflammatory state. In addition to anticoagulant effects, heparin and its derivatives have...

    Authors: Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Awatif Hafiz, Mai Alalawi, Hisham A. Badreldin, Ali F. Altebainawi, Ramesh Vishwakarma, Abdulrahman Alissa, Albandari Alghamdi, Abeer A. Alenazi, Huda Al Enazi, Shahad Alanazi, Abdullah Alhammad, Jahad Alghamdi, Mashael AlFaifi…
    Citation: Thrombosis Journal 2022 20:74
    Content type: Research Published on:

  42. Acutely ill medical patients experience deep venous thrombosis (DVT) during the hospitalization, however the time course of DVT is still unclear.

    Authors: Lorenzo Loffredo, Gianpaolo Vidili, Angela Sciacqua, Chiara Cogliati, Rosella Di Giulio, Sciaila Bernardini, Paolo Ciacci, Antonello Pietrangelo, Federica Orlando, Aurora Paraninfi, Maria Boddi, Giovanni Di Minno, Lorenzo Falsetti, Corrado Lodigiani, Angelo Santoliquido, Evaristo Ettorre…
    Citation: Thrombosis Journal 2022 20:72
    Content type: Research Published on:

  43. Patients with end-stage kidney disease on haemodialysis suffer from frequent complications requiring hospitalisation. Atrial fibrillation is a burdensome comorbidity amongst patients on haemodialysis. We aimed...

    Authors: Daniel Steiner, Sabine Schmaldienst, Matthias Lorenz, Renate Klauser-Braun, Ingrid Pabinger, Cihan Ay, Marcus Säemann and Oliver Königsbrügge
    Citation: Thrombosis Journal 2022 20:71
    Content type: Research Published on:

  44. Thrombotic complications are synergistic and associated with orthopedic procedures, trauma, and malignancy. Because cancer enhances coagulation activity and vice versa, we assessed preoperative biomarkers for ...

    Authors: Sanna Matilainen, Gilber Kask, Jyrki Nieminen, Riitta Lassila and Minna Laitinen
    Citation: Thrombosis Journal 2022 20:70
    Content type: Research Published on:

  45. It is well established that lipoprotein(a)[Lp(a)] play a vital role in atherosclerosis. Whether Lp(a) can predict recurrence of cardiovascular events (CVEs) in prior CVEs patients is still unclear. We aim to i...

    Authors: Na Xu, Yi Yao, Lin Jiang, Jingjing Xu, Huanhuan Wang, Ying Song, Yuejin Yang, Bo Xu, Runlin Gao and Jinqing Yuan
    Citation: Thrombosis Journal 2022 20:69
    Content type: Research Published on:

  46. Venous thromboembolism (VTE) is a life-threatening cardiovascular syndrome that characterized by the imbalance of hemostasis and thrombosis and the formation of thrombi in the blood vessels. The aim of this st...

    Authors: Ziran Wang, Lingjun Kong, Guoju Luo, Han Zhang, Fengchun Sun, Wenjuan Liang, Wei Wu, Zijian Guo, Rui Zhang and Yaling Dou
    Citation: Thrombosis Journal 2022 20:68
    Content type: Research Published on:

  47. The relationship between vascular endothelial growth factor (VEGF) and the risk of venous thromboembolism (VTE) has always been one of the concerns in the medical field. However, the causal inferences from pub...

    Authors: Qiaoyun Zhang, Xiaoyu Zhang, Jie Zhang, Biyan Wang, Qiuyue Tian, Xiaoni Meng, Jinxia Zhang, Mengyang Jiang, Yiqiang Zhang, Deqiang Zheng, Lijuan Wu, Wei Wang, Baoguo Wang and Youxin Wang
    Citation: Thrombosis Journal 2022 20:67
    Content type: Research Published on:

  48. This study aimed to evaluate the efficacy and safety of oral anticoagulants (OACs) in real-world elderly patients with comorbidities of stable coronary artery disease (SCAD) and atrial fibrillation (AF).

    Authors: Xu Zhang, Yangxun Wu, Chao Lv, Shizhao Zhang, Haiping Liu, Yuyan Wang, Yuting Zou, Liu’an Qin, Junmeng Zhang and Tong Yin
    Citation: Thrombosis Journal 2022 20:66
    Content type: Research Published on:

  49. Warfarin is the most widely used oral anticoagulant; nevertheless, dosing of warfarin is problematic for clinicians worldwide. Inter-individual variability in response to warfarin is attributed to genetic as w...

    Authors: Weam Aldiban, Yara Altawil, Samir Hussein, Majd Aljamali and Lama A. Youssef
    Citation: Thrombosis Journal 2022 20:65
    Content type: Case Report Published on:

  50. Vitamin K antagonists and different direct oral anticoagulants (DOACs) have different renal clearance rates. However, the impact of different stages of chronic renal impairment on the efficacy and safety of wa...

    Authors: Wei-Chieh Lee, Ting-Wei Liao, Hsiu-Yu Fang, Po-Jui Wu, Yen-Nan Fang, Huang-Chung Chen, Yu-Sheng Lin, Shang-Hung Chang, Ping-Yen Liu and Mien-Cheng Chen
    Citation: Thrombosis Journal 2022 20:64
    Content type: Research Published on:
Submit manuscript

Official journal of

  • APSTH logo

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.011 - SNIP (Source Normalized Impact per Paper)
    0.699 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    107 days submission to accept (Median)

    2023 Usage 
    708,004 downloads
    943 Altmetric mentions 

Thrombosis Journal

ISSN: 1477-9560

Contact us